BALA MOHAN (SVP, Chief Development Officer) sold 21.4% of their position (13.69K shares) of MERSANA THERAPEUTICS, INC. on the open market
Open‑market sale worth $27.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/7/2024ACC: 0001104659-24-106749
Officer· SVP, Chief Development Officer
Since Sep 2023
-13.69K
Net shares
Net seller
$27.2K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
50K acquired · 63.69K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
355.8%
10/1/2024
14.05K→64.05K
Common Stock
Direct
Shares
−8.09K
Price / share
$2.00
Trade value
$16.18K
% of position
12.6%
10/2/2024
64.05K→55.96K
Common Stock
Direct
Shares
−5.60K
Price / share
$1.96
Trade value
$10.97K
% of position
10.0%
10/3/2024
55.96K→50.37K
Total
Net shares
+36.31K
Net value
-$27.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2024 | M · Option Exercise | +50K | — | — | 355.8% | 14.05K | 64.05K |
| Common Stock Direct | 10/2/2024 | S · Sale | −8.09K | $2.00 | $16.18K | 12.6% | 64.05K | 55.96K |
| Common Stock Direct | 10/3/2024 | S · Sale | −5.60K | $1.96 | $10.97K | 10.0% | 55.96K | 50.37K |
| Total | +36.31K | -$27.15K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
Held after
0.00
Exercisable
—
10/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock50K shares | 10/1/2024 | M · Option Exercise | −50K | — | 0.00 |